16/09/25 DiaMonTech AG announced that it has received ?8 million in funding from Samsung NEXT, LLC CI
26/11/24 DiaMonTech AG announced that it has received funding from Disrupt Health Impact Fund CI
07/12/23 DiaMonTech AG announced that it has received funding from Moll Family GmbH, and other investors CI
17/02/22 DiaMonTech AG announced that it has received $5 million in funding from IBB Beteiligungsgesellschaft mbH, Unorthodox Ventures, Samsung Venture Investment Corporation CI
26/11/19 DiaMonTech AG has withdrawn its IPO in the amount of €59.375 million. CI
25/11/19 DAK-Gesundheit and DiaMonTech AG Plan Strategic Cooperation in the Non-Invasive Blood Glucose Monitoring Sector for New Treatment Strategies in the Diabetes Sector CI
13/11/19 DiaMonTech AG has filed an IPO in the amount of €59.375 million. CI
11/11/19 DiaMonTech AG Signs A Further Agreement with an International Sales Company CI
21/10/19 DiaMonTech GmbH Publishes Results of Clinical Study Confirming the Accuracy of its Non-Invasive Blood Glucose-Monitoring Technology CI
01/10/19 DiaMonTech GmbH Appoints Enrico Just as Managing Director and CFO CI
16/09/19 Deutscher Apothekerverband e. V. & DiaMonTech GmbH Intends Strategic Cooperation to Significantly Improve the Care of Diabetes Patients and to Take an Innovative Step into the Future CI
09/09/19 DiaMonTech GmbH announced that it has received €7 million in funding from IBB Beteiligungsgesellschaft mbH, Bioventure Consulting GmbH, and other investors CI
05/09/18 DiaMonTech GmbH announced that it has received funding from IBB Beteiligungsgesellschaft mbH, Macnica, Inc., Jindong Investment Group Co., Ltd. CI
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 10/01/2015
Chief Executive Officer 52 01/04/2015
Director of Finance/CFO - 01/10/2019
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 0
+4.16%+3.04%+49.37%+94.17% 74.16B
+0.71%-2.77%+20.80%+80.05% 57.39B
+0.62%-2.43%+2.30%+35.75% 47.64B
+0.36%+0.81%+342.39%+748.97% 44.29B
-0.96%-4.50%+24.96%+31.45% 42.5B
-0.20%-0.77%+4.13%+111.69% 40.71B
-0.54%+2.93%+9.31%+54.06% 30.97B
+1.56%+3.75%+31.90%+29.14% 28.53B
+0.05%-1.64%-8.14%-12.10% 24.34B
Average +0.57%-0.59%+53.00%+130.35% 43.39B
Weighted average by Cap. +0.95%-0.84%+57.25%+139.68%
Logo DiaMonTech AG
DiaMonTech AG is a Germany-based medical device company. It develops a device for non-invasive measuring of glucose levels in diabetes patients. The device is based on spectroscopy and uses photothermal detection technology. The device range under development includes a desktop device for clinical settings and multiple users, as well as a compact pocket device for the end user.
Employees
-